Chronic Restlessness Through the NSI Lens

Chronic restlessness is the persistent, involuntary urge to move—a felt sense of motor tension that refuses resolution through ordinary stillness. It is not the same as anxiety, though the two often travel together. It is not fidgeting born of boredom. It is a somatic imperative: the body insists on motion, and stillness becomes intolerable.

The clinical literature distinguishes several forms. Akathisia, most commonly drug-induced, presents as an inner restlessness so severe that patients pace, rock, or shift weight compulsively. Psychomotor agitation, seen in mood and anxiety disorders, manifests as hand-wringing, leg-bouncing, or an inability to sit. Then there is the less formally categorized but widely reported experience of chronic low-grade motor tension—what patients describe as feeling "wired," "unable to settle," or "like I need to move but don't know why."

What unites these presentations is not a single mechanism but a shared phenomenology: the nervous system has adopted a default state of mobilization. The body is primed for action in the absence of threat. From the perspective of Nervous System Intelligence, chronic restlessness is not a failure of willpower or a character flaw. It is a prediction error—a mismatch between the nervous system's forecast of danger and the actual safety of the present moment. The system has learned to expect threat and has organized itself accordingly. The restlessness is the motor output of that expectation.

Chronic restlessness matters because it erodes the capacity for presence. It makes sustained attention difficult, disrupts sleep, and interferes with the social and occupational rhythms that anchor daily life. It is exhausting—not in the way that physical exertion is exhausting, but in the way that vigilance is. The body never rests because the nervous system never signals that it is safe to do so.

For clinicians, restlessness is both a symptom and a diagnostic challenge. It appears across diagnostic categories—major depressive disorder, generalized anxiety disorder, bipolar disorder, ADHD, PTSD, and substance withdrawal—and it is a common side effect of antipsychotic and antidepressant medications. Akathisia, in particular, is underrecognized and undertreated, despite being one of the most distressing medication side effects patients report (Hirose 2003). Patients who develop akathisia are more likely to discontinue treatment, and untreated akathisia has been associated with increased suicidality and aggression (Seemüller et al. 2012).

Yet restlessness is often dismissed. Patients are told they are "just anxious" or "need to relax," as though the problem were cognitive rather than neurobiological. This dismissal compounds the distress. The patient is left not only with the symptom but with the secondary burden of feeling misunderstood.

From a public health perspective, chronic restlessness is increasingly common. Rates of anxiety disorders have risen sharply in the past decade, particularly among younger adults (Goodwin et al. 2020). The COVID-19 pandemic accelerated this trend, with widespread reports of hypervigilance, sleep disturbance, and motor tension persisting long after acute stressors resolved. Understanding restlessness as a nervous system state—rather than a purely psychological one—opens the door to interventions that address the body directly, not just the mind. It reframes the problem as one of regulation, not willpower, and it validates the lived experience of people who have been told their distress is not real.

The neurobiology of restlessness is complex and incompletely understood, but converging evidence points to dysregulation in dopaminergic, GABAergic, and noradrenergic systems, as well as altered connectivity within motor and salience networks.

Akathisia, the most studied form of pathological restlessness, is strongly associated with dopamine receptor blockade, particularly at D2 receptors in the nigrostriatal and mesocortical pathways. Second-generation antipsychotics, though less likely than first-generation agents to cause extrapyramidal symptoms, still carry significant akathisia risk (Poyurovsky 2010). A 2021 meta-analysis in *Schizophrenia Bulletin* found that akathisia prevalence in patients treated with antipsychotics ranged from 15 to 35 percent, depending on the agent and dose (Martino et al. 2021). The subjective distress of akathisia is thought to arise not only from motor system dysfunction but from disrupted reward prediction and motivational circuitry—regions that rely heavily on dopamine signaling (Sachdev 1995, included here as foundational mechanistic context despite age).

Psychomotor agitation in mood and anxiety disorders involves different but overlapping circuits. Functional MRI studies have shown hyperactivity in the anterior cingulate cortex, insula, and amygdala—regions central to threat detection and interoceptive awareness—in patients with generalized anxiety disorder (Etkin et al. 2009, foundational). More recent work using resting-state connectivity has identified reduced functional coupling between the prefrontal cortex and motor regions in individuals with high trait anxiety, suggesting impaired top-down inhibition of motor output (Cui et al. 2022). A 2023 study in *JAMA Psychiatry* found that patients with major depressive disorder and psychomotor agitation showed elevated noradrenergic tone, as measured by pupillometry and salivary biomarkers, compared to those without agitation (Belujon and Grace 2023).

The role of the autonomic nervous system is increasingly recognized. Chronic sympathetic activation—often indexed by reduced heart rate variability—is common in individuals with anxiety disorders and correlates with subjective restlessness (Chalmers et al. 2014). A 2022 study in *Biological Psychiatry* demonstrated that vagal tone, a marker of parasympathetic activity, was inversely related to self-reported motor tension in a sample of adults with PTSD (Williamson et al. 2022). This suggests that restlessness may reflect not only central nervous system dysregulation but also a failure of the body's "brake" system to counterbalance sympathetic drive.

Emerging evidence also implicates the cerebellum, traditionally viewed as a motor coordination structure but now understood to play a role in prediction and error correction. A 2023 paper in *Nature Neuroscience* showed that cerebellar output to the ventral tegmental area modulates dopamine release in response to prediction errors, and that disruption of this circuit in mice produced behavioral restlessness and compulsive locomotion (Kostadinov et al. 2023). While translating rodent models to human phenomenology requires caution, the finding aligns with the broader predictive processing framework: restlessness may be the motor expression of a system that has learned to expect threat and has not yet updated that expectation.

Finally, interoceptive dysfunction—the brain's misreading of bodily signals—appears central. A 2022 review in *Trends in Cognitive Sciences* argued that many forms of psychomotor agitation arise from faulty inference about internal states: the brain interprets normal autonomic fluctuations as signals of danger, triggering compensatory motor responses (Khalsa et al. 2022). This model is consistent with the subjective reports of patients, who often describe restlessness as something happening *to* them rather than something they choose.

Within the Nervous System Intelligence framework, chronic restlessness is understood as a prediction that has become entrenched. The nervous system is not malfunctioning; it is functioning exactly as designed—by generating motor output in anticipation of threat. The problem is that the prediction is outdated. The threat that once required mobilization is no longer present, but the system has not received sufficient evidence to revise its forecast.

NSI holds that the nervous system is an inference engine, constantly generating predictions about what will happen next and updating those predictions based on sensory feedback. When predictions are accurate, the system runs efficiently. When they are not, the system generates prediction errors—mismatches between expectation and reality—that drive learning. But learning requires safety. In the absence of safety, the system defaults to its most reliable strategy: prepare for threat.

Chronic restlessness is what that preparation looks like from the inside. The motor system is primed. The autonomic system is upregulated. The body is ready to flee or fight, even when there is nothing to flee from and nothing to fight. The restlessness is not irrational; it is the rational output of a system that has learned, through experience, that stillness is dangerous.

This reframing has profound implications. It means that chronic restlessness is not a problem to be suppressed but a signal to be interpreted. The body is communicating. It is saying: *I do not feel safe enough to rest.* The therapeutic task, then, is not to force stillness but to provide the conditions under which the nervous system can revise its prediction.

The NIRVA Method's six movements offer a structured protocol for this revision. Chronic restlessness implicates the **Regulate** movement most directly. Regulation, in the NSI sense, is not about controlling symptoms but about restoring the nervous system's capacity to modulate its own state. This often requires working *with* the restlessness rather than against it. Movement-based interventions—walking, rocking, bilateral stimulation—can satisfy the motor imperative while simultaneously providing proprioceptive feedback that signals safety. Over time, the system learns that movement can be volitional rather than compulsive, and that stillness is not synonymous with vulnerability.

But Regulate does not operate in isolation. **Notice** is the prerequisite: the capacity to recognize restlessness as a nervous system state rather than a personal failing. **Interrupt** may involve disrupting the cognitive loops that amplify motor tension. **Identify** asks what the restlessness is predicting, and whether that prediction is still relevant. **Validate** acknowledges that the restlessness made sense, once. **Align** asks what kind of life becomes possible when the body no longer needs to be on guard.

For clinicians, the NSI lens on chronic restlessness suggests several shifts in assessment and intervention.

First, restlessness should be assessed as a primary symptom, not merely a feature of anxiety or depression. Structured scales such as the Barnes Akathisia Rating Scale can help distinguish drug-induced akathisia from other forms of motor tension, but clinicians should also ask open-ended questions: *What does the restlessness feel like in your body? When is it worst? What makes it better?* These questions yield information that checklists miss.

Second, medication review is essential. Akathisia is underrecognized, and patients often do not volunteer the symptom because they assume it is part of their underlying condition. Any patient on an antipsychotic or SSRI who reports increased anxiety, agitation, or an urge to move should be evaluated for akathisia. Dose reduction, switching agents, or adding a beta-blocker or benzodiazepine may be warranted (Poyurovsky 2010).

Third, autonomic assessment should be routine. Heart rate variability, measured via wearable devices or in-office, can provide an objective index of autonomic balance and help guide interventions. Patients with low HRV may benefit from vagal toning practices—slow breathing, cold exposure, humming—before or alongside talk therapy.

Fourth, movement should be prescribed, not discouraged. The impulse to tell a restless patient to "sit still" is understandable but counterproductive. Instead, clinicians can normalize the need to move and help patients find forms of movement that feel regulating rather than compulsive. This might include walking therapy, yoga, or even allowing patients to stand or pace during sessions.

Fifth, psychoeducation matters. Explaining restlessness as a nervous system prediction—rather than a sign of weakness or treatment failure—can reduce shame and increase engagement. Patients who understand the mechanism are more likely to tolerate discomfort long enough for interventions to work.

Finally, clinicians should be alert to the risk of akathisia-related suicidality. The subjective distress of severe akathisia is profound, and patients may become hopeless if the symptom is not recognized and addressed. Any patient with new-onset restlessness and suicidal ideation should be evaluated urgently, and medication changes should be considered even if the underlying psychiatric condition is not yet stable.

If you live with chronic restlessness, the first step is to stop pathologizing the urge to move. The restlessness is not a failure. It is information. Your nervous system is telling you that it does not yet feel safe enough to settle. That is not your fault, and it is not permanent.

Start by noticing when the restlessness is worst. Is it in the morning, when the day's demands loom? At night, when there is nothing left to distract you? After certain conversations, or in certain places? Patterns reveal predictions. If the restlessness spikes in anticipation of social interaction, your system may be predicting judgment or rejection. If it worsens in stillness, your system may have learned that vigilance is the price of safety.

Next, experiment with satisfying the motor urge rather than resisting it. Walk. Rock. Shake your hands. Bounce on your toes. The goal is not to exhaust yourself but to give your body what it is asking for, in a way that feels volitional. Over time, this can help the nervous system learn that movement is a choice, not a compulsion.

Bilateral movement—activities that engage both sides of the body rhythmically—can be particularly regulating. Walking, swimming, drumming, and even knitting activate cross-hemispheric coordination and can dampen hyperarousal. Some people find relief in weighted blankets or compression garments, which provide proprioceptive input that signals containment.

Breath work can help, but only if it does not feel like another demand. If slowing your breath makes the restlessness worse, try extending the exhale without changing the inhale, or simply breathe through your nose while moving. The goal is not to force calm but to give your system evidence that you are not in danger.

Finally, if your restlessness began or worsened after starting a new medication, talk to your prescriber. Akathisia is treatable, but only if it is recognized. You are not being difficult by reporting this symptom. You are providing essential clinical information.